Home › Compare › RUBLF vs JNJ

RUBLF vs JNJ: Dividend Comparison 2026

RUBLF yields 79.05% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RUBLF wins by $1.57M in total portfolio value
10 years
RUBLF
RUBLF
● Live price
79.05%
Share price
$2.53
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.59M
Annual income
$455,857.98
Full RUBLF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RUBLF vs JNJ

📍 RUBLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRUBLFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RUBLF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RUBLF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RUBLF
Annual income on $10K today (after 15% tax)
$6,719.37/yr
After 10yr DRIP, annual income (after tax)
$387,479.28/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, RUBLF beats the other by $386,775.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RUBLF + JNJ for your $10,000?

RUBLF: 50%JNJ: 50%
100% JNJ50/50100% RUBLF
Portfolio after 10yr
$805.1K
Annual income
$228,342.88/yr
Blended yield
28.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RUBLF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
1.8
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RUBLF buys
0
JNJ buys
0
No recent congressional trades found for RUBLF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRUBLFJNJ
Forward yield79.05% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$1.59M$20.0K ✓
Annual income after 10y$455,857.98 ✓$827.78
Total dividends collected$1.38M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: RUBLF vs JNJ ($10,000, DRIP)

YearRUBLF PortfolioRUBLF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$18,605$7,905.14$10,676$355.77+$7.9K → RUBLF
2$33,653$13,745.44$11,407$389.39+$22.2K → RUBLF
3$59,245$23,236.19$12,198$426.53+$47.0K → RUBLF
4$101,622$38,230.38$13,056$467.62+$88.6K → RUBLF
5$170,022$61,286.33$13,987$513.12+$156.0K → RUBLF
6$277,753$95,828.86$14,998$563.56+$262.8K → RUBLF
7$443,502$146,306.97$16,098$619.52+$427.4K → RUBLF
8$692,880$218,332.77$17,295$681.69+$675.6K → RUBLF
9$1,060,167$318,784.67$18,599$750.82+$1.04M → RUBLF
10$1,590,236$455,857.98$20,022$827.78+$1.57M → RUBLF

RUBLF vs JNJ: Complete Analysis 2026

RUBLF — Stock

Rubellite Energy Inc. engages in the exploration, development, production, and sale of heavy crude oil from the Clearwater Formation in Eastern Alberta. The company was incorporated in 2021 and is headquartered in Calgary, Canada. Rubellite Energy Inc. is a subsidiary of Perpetual Energy Inc.

Full RUBLF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RUBLF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RUBLF vs SCHDRUBLF vs JEPIRUBLF vs ORUBLF vs KORUBLF vs MAINRUBLF vs ABBVRUBLF vs MRKRUBLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.